Cellartis

Cellartis AB is a Swedish/British biotechnology company focused on human embryonic stem (hES) cells for drug discovery, toxicity testing and regenerative medicine with the main objective to develop hepatocytes and cardiomyocytes from these cells.

Read more

 

New PRODUCTS

cardiomyocyte_clusters.jpg Mesenchymal Progenitors SCED™461 cells

We offer a panel of unique functional human cell types derived from human embryonic stem (hES) cells and associated hES cell products, specifically human cardiomyocytes (hES-CMC) and mesenchymal progenitors (hES-MP) derived from hES cells.

Read more
     

Project activities
cardiomyocytes.png

CARDIOMYOCYTES
Cellartis has developed spontaneously contracting human cardiomyocytes derived from human embryonic stem cells enabling evaluation in a close to physiologic environment.
Read more

hepatocytes.png

HEPATOCYTES
Cellartis improves robust protocols that allow consistent differentiation of hES cells into homogenous populations of functional hepatocytes suitable for use as bio-tools in industrial applications.
Read more

platform-and-assay-development.png

PLATFORM AND ASSAY DEVELOPMENT
Cellartis has long experience and thorough know-how in stem cell platform technology enabling an exceptional environment for quality controlled scale-up of hES culture and development of hES based assays and tools.
Read more